EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Novel endoscopic scoring system for immune mediated colitis: a multicenter retrospective study of 674 patients

Yinghong Wang, Hamzah Abu-Sbeih, Tenglong Tang, Malek Shatila, David Faleck, Jessica Harris, Michael Dougan, Anna Olsson-Brown, Douglas B Johnson, Chanjuan Shi, Petros Grivas, Leonidas Diamantopoulos und 19 weitere

Gastrointestinal Endoscopy · 2024-08 · 100 (2) · 273-282.e4

DOI: 10.1016/j.gie.2024.01.024 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Gastrointestinal Endoscopy, 2024-08. Verfasst von Yinghong Wang und 30 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Electronic address:…. Hauptthemen laut MEDLINE: Colitis, Severity of Illness Index, Colonoscopy. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIMS: No endoscopic scoring system has been established for immune-mediated colitis (IMC). This study aimed to establish such a system for IMC and explore its utility in guiding future selective immunosuppressive therapy (SIT) use compared to clinical symptoms. METHODS: This retrospective, international, 14-center study included 674 patients who developed IMC after immunotherapy and underwent endoscopic evaluation. Ten endoscopic features were selected by group consensus and assigned 1 point each to calculate an IMC endoscopic score (IMCES). IMCES cutoffs were chosen to maximize specificity for SIT use. This specificity was compared between IMCESs, and clinical symptoms were graded according to a standardized instrument. RESULTS: A total of 309 (45.8%) patients received SIT. IMCES specificity for SIT use was 82.8% with a cutoff of 4. The inclusion of ulceration as a mandatory criterion resulted in higher specificity (85.0% for a cutoff of 4). In comparison, the specificity of a Mayo endoscopic subscore of 3 was 74.6%, and the specificity of clinical symptom grading was much lower at 27.4% and 12.3%, respectively. Early endoscopy was associated with timely SIT use (P < .001; r = 0.4084). CONCLUSIONS: This is the largest multicenter study to devise an endoscopic scoring system to guide IMC management. An IMCES cutoff of 4 has a higher specificity for SIT use than clinical symptoms, supporting early endoscopic evaluation for IMC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColitisSeverity of Illness IndexColonoscopyHumansRetrospective StudiesMaleFemaleMiddle AgedAdultImmunosuppressive AgentsAgedImmunotherapySensitivity and SpecificityUlcer

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Electronic address: ywang59@mdanderson.org.
  • Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of Internal Medicine, University of Missouri, Kansas City, Missouri, USA.
  • Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA; Department of General Surgery, The Second Xiangya Hospital of Central South University, C…
  • Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Gastroenterology, Hepatology and Nutrition Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA.

Förderung

  • Wellcome Trust
  • NCI NIH HHS

Zitieren

APA

Wang, Y., Abu-Sbeih, H., Tang, T., Shatila, M., Faleck, D., Harris, J., Dougan, M., Olsson-Brown, A., Johnson, D. B., Shi, C., Grivas, P., Diamantopoulos, L., Owen, D. H., Cassol, C., Arnold, C. A., Warner, D. E., Alva, A., Powell, N., Ibraheim, H., …, & Qiao, W. (2024). Novel endoscopic scoring system for immune mediated colitis: a multicenter retrospective study of 674 patients. Gastrointestinal Endoscopy, 100(2), 273-282.e4. https://doi.org/10.1016/j.gie.2024.01.024

Vancouver

Wang Y, Abu-Sbeih H, Tang T, Shatila M, Faleck D, Harris J, et al. Novel endoscopic scoring system for immune mediated colitis: a multicenter retrospective study of 674 patients. Gastrointestinal Endoscopy. 2024;100(2):273-282.e4. doi:10.1016/j.gie.2024.01.024

BibTeX
@article{Wang2024,
  author = {Wang, Yinghong and Abu-Sbeih, Hamzah and Tang, Tenglong and Shatila, Malek and Faleck, David and Harris, Jessica and Dougan, Michael and Olsson-Brown, Anna and Johnson, Douglas B and Shi, Chanjuan and Grivas, Petros and Diamantopoulos, Leonidas and Owen, Dwight H and Cassol, Clarissa and Arnold, Christina A and Warner, David E and Alva, Ajjai and Powell, Nick and Ibraheim, Hajir and De Toni, Enrico N and Philipp, Alexander B and Philpott, Jessica and Sleiman, Joseph and Lythgoe, Mark and Daniels, Ella and Sandhu, Shahneen and Weppler, Alison M and Buckle, Andrew and Pinato, David J and Thomas, Anusha and Qiao, Wei},
  title = {Novel endoscopic scoring system for immune mediated colitis: a multicenter retrospective study of 674 patients},
  journal = {Gastrointestinal Endoscopy},
  year = {2024},
  volume = {100},
  number = {2},
  pages = {273--282.e4},
  doi = {10.1016/j.gie.2024.01.024}
}
Kostenlos starten →